JH-013 / Biotech Pharma - LARVOL DELTA

Dose-Response Relationship of JH013, a Novel Neuromuscular Blocking Agent, in Common Marmosets (ASA 2026) - "Abstract is embargoed at this time."

JH013 Injection in Patients With Primary Sjögren's Syndrome (clinicaltrials.gov) - P1 | N=54 | Not yet recruiting | Sponsor: Biotech Pharmaceutical Co., Ltd.

New P1 trial